MbrlCatalogueTitleDetail

Do you wish to reserve the book?
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes
The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes
Journal Article

The patient reported intraocular lens questionnaire (PR-ILQ): content validity, psychometric performance, and use in a regulated clinical trial to evaluate safety and effectiveness outcomes

2025
Request Book From Autostore and Choose the Collection Method
Overview
Background Patient-reported outcomes (PROs) are underutilized in medical device evaluations, including in ophthalmology and intraocular lens (IOL) replacements. This article summarizes research conducted to develop the Patient-Reported Intraocular Lens Questionnaire (PR-ILQ) and support its content validity and psychometric performance. Use of the PR-ILQ in a regulated clinical trial to support new product approval decisions, secondary effectiveness claims, and safety observations is also discussed. Results The PR-ILQ, developed with ophthalmology experts ( n  = 10) and use of qualitative data generated from patients during concept elicitation ( n  = 44) and cognitive debriefing ( n  = 32) interviews, includes the Vision Correction Scale (VCS, three items), Vision Disturbance Scale (VDS, eight items), and IOL Replacement Satisfaction Scale (IOL-RSS, five items). Each assessment is distinct, and items within each are scored independently to address treatment benefit hypotheses. With its content validity established, the PR-ILQ was administered to 271 subjects (mean age = 68.3 years) participating in a clinical trial to evaluate the safety and effectiveness of an asymmetric segmented multifocal IOL (SBL-INI-02–13). Descriptively, item scores behaved as expected, with clustering of VCS and VDS scores at more- and less-severe levels at study entry and exit, respectively, though scores were distributed across response options across timepoints. Test-retest reliability results mostly indicate “fair”/“good” (weighted Kappa [KW]/intraclass correlation coefficient [ICC] > 0.40 to 0.60) to “excellent” (KW/ICC > 0.75) reproducibility for VCS, VDS, and IOL-RSS items in two independent analyses. Construct validity hypotheses, including those associated with sensitivity to change, were supported via correlational analysis showing a pattern of expected relationships among PR-ILQ items and with other variables including ratings of visual acuity. For example, reduced use of vision correction at near ( r  = −0.28), intermediate ( r  = −0.42), and far ( r  = −0.57) distances were more strongly related to overall lens satisfaction at end of study than improved visual acuity at those same distances ( r  = −0.25. −0.26, and −0,14). Conclusions The PR-ILQ is content valid and early evidence suggests it is capable of producing reliable scores upon which valid conclusions may be drawn when administered among patients undergoing cataract lens replacement surgery. Acknowledging limitations and need for additional psychometric evaluation, the assessment recently supported a new product approval decision, secondary effectiveness claims, and safety observations. Together, this indicates that the PR-ILQ, along with the evidentiary basis and suggestions for use presented herein, will be of immediate value to IOL replacement outcomes researchers, regulators, and other stakeholders interested in generating evidence to inform health care decisions and improving cataracts patients’ lives. Trial registration Clinicaltrials.gov, NCT02487160. Registered 25 June 2015, https://clinicaltrials.gov/study/NCT02487160 .